Nonenzymatic Glycation and Degree of Mineralization Are Higher in Bone from Fractured Patients with Type 1 Diabetes Mellitus

Journal of Bone and Mineral Research

Volumn 31, Issue 1, 2016, Pages 190-195

  Farlay, Delphine ^a,b   Armas, Laura A G ^c   Gineyts, Evelyne ^a,b   Akhter, Mohammed P ^c   Recker, Robert R ^c   Boivin, Georges ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE LYON   (France)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BONE QUALITY; FRACTURE; MINERALIZATION; PENTOSIDINE; TYPE 1 DIABETES MELLITUS

Indexed keywords

HEMOGLOBIN A1C; PENTOSIDINE; ADVANCED GLYCATION END PRODUCT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BONE BIOPSY; BONE MATRIX; BONE MINERALIZATION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CORTICAL BONE; CROSS-SECTIONAL STUDY; FEMALE; FRACTURE; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ILIAC CREST; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICRORADIOGRAPHY; TRABECULAR BONE; BONE DENSITY; DIABETES MELLITUS; DIAGNOSTIC IMAGING; FRACTURES, BONE; METABOLISM; MIDDLE AGED; RADIOGRAPHY;

ADULT; BONE DENSITY; CALCIFICATION, PHYSIOLOGIC; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; FRACTURES, BONE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; RADIOGRAPHY;

EID: 84957706554     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2607     Document Type: Article

References (23)

1. Farr JN, Drake MT, Amin S, Melton LJ, 3rd, McCready LK, Khosla S,. In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res 2014; 29 (4): 787-95.
2. Nicodemus KK, Folsom AR., Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 2001; 24 (7): 1192-7.
3. Jehle PM, Jehle DR, Mohan S, Bohm BO,. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. J Endocrinol. 1998; 159 (2): 297-306.
4. Joshi A, Varthakavi P, Chadha M, Bhagwat N,. A study of bone mineral density and its determinants in type 1 diabetes mellitus. J Osteoporos. 2013; 2013: 397814.
5. Miao J, Brismar K, Nyren O, Ugarph-Morawski A, Ye W., Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden. Diabetes Care. 2005; 28 (12): 2850-5.
6. Janghorbani M, Van Dam RM, Willett WC, Hu FB,. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007; 166 (5): 495-505.
7. Vestergaard P., Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int. 2007; 18 (4): 427-44.
8. Weber G, Beccaria L, de'Angelis M, et al., Bone mass in young patients with type I diabetes. Bone Miner. 1990; 8 (1): 23-30.
9. Gallacher SJ, Fenner JA, Fisher BM, et al., An evaluation of bone density and turnover in premenopausal women with type 1 diabetes mellitus. Diabet Med. 1993; 10 (2): 129-33.
10. Armas LA, Akhter MP, Drincic A, Recker RR,. Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus. Bone. 2012; 50 (1): 91-6.
11. Bailey AJ, Paul RG, Knott L., Mechanisms of maturation and ageing of collagen. Mech Ageing Dev. 1998; 106 (1-2): 1-56.
12. Vashishth D., The role of the collagen matrix in skeletal fragility. Curr Osteoporos Rep. 2007; 5 (2): 62-6.
13. Dong XN, Qin A, Xu J, Wang X,. In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption. Bone. 2011; 49 (2): 174-83.
14. Schwartz AV, Garnero P, Hillier TA, et al., Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab. 2009; 94 (7): 2380-6.
15. Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T,. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab. 2008; 93 (3): 1013-9.
16. Neumann T, Lodes S, Kastner B, et al., High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control. Osteoporos Int. 2014; 25 (5): 1527-33.
17. Currey JD., Tensile yield in compact bone is determined by strain, post-yield behaviour by mineral content. J Biomech. 2004; 37 (4): 549-56.
18. Viguet-Carrin S, Gineyts E, Bertholon C, Delmas PD,. Simple and sensitive method for quantification of fluorescent enzymatic mature and senescent crosslinks of collagen in bone hydrolysate using single-column high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877(1-2): 1-7.
19. Montagner F, Kaftandjian V, Farlay D, Brau D, Boivin G, Follet H,. Validation of a novel microradiography device for characterization of bone mineralization. J Xray Sci Technol. 2015; 23 (2): 201-11.
20. Boivin G, Bala Y, Doublier A, et al., The role of mineralization and organic matrix in the microhardness of bone tissue from controls and osteoporotic patients. Bone. 2008; 43 (3): 532-8.
21. Polly BJ, Yuya PA, Akhter MP, Recker RR, Turner JA,. Intrinsic material properties of trabecular bone by nanoindentation testing of biopsies taken from healthy women before and after menopause. Calcif Tissue Int. 2012; 90 (4): 286-93.
22. Zhukouskaya VV, Eller-Vainicher C, Vadzianava VV, et al., Prevalence of morphometric vertebral fractures in patients with type 1 diabetes. Diabetes Care. 2013; 36 (6): 1635-40.
23. Koehne T, Vettorazzi E, Kusters N, et al., Trends in trabecular architecture and bone mineral density distribution in 152 individuals aged 30-90 years. Bone. 2014; 66: 31-8.